| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |